IC
RXDX

Ikarian Capital’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Ikarian Capital’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-125,926
Closed -$13.5M – 126
2023
Q1 		$13.5M Sell
125,926
-163,000
-56% -$17.5M 3.07% 1
2022
Q4 		$31.8M Buy
288,926
+57,745
+25% +$6.35M 7.67% 1
2022
Q3 		$13.6M Buy
+231,181
New +$13.6M 2.72% 3